Alkem Laboratories re-appoints Madhurima Singh as Executive Director
Alkem Laboratories Limited’s Board has approved the re-appointment of Mrs. Madhurima Singh as an Executive Director for a term of five years, effective from December 20, 2026, subject to shareholder approval.
*this image is generated using AI for illustrative purposes only.
Alkem Laboratories Limited’s Board has approved the re-appointment of Mrs. Madhurima Singh as an Executive Director for a term of five years, effective from December 20, 2026. The decision, taken at the Board meeting held on May 28, 2026, is based on the recommendations of the Nomination and Remuneration Committee and the Audit Committee. The re-appointment is subject to the approval of shareholders at the ensuing Annual General Meeting.
The appointment extends Mrs. Singh’s tenure until December 19, 2031. The disclosure was made to the exchanges pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Details of Re-appointment
The following table outlines the key details of the re-appointment:
| Sr. No. | Particulars | Details |
|---|---|---|
| 1. | Name | Mrs. Madhurima Singh |
| 2. | Reason for change | Re-appointment of Mrs. Madhurima Singh as an Executive Director of the Company. |
| 3. | Date of Re-appointment | December 20, 2026 |
| 4. | Term of Re-appointment | 5 (five) consecutive years with effect from December 20, 2026 upto December 19, 2031. |
The company has informed BSE Limited and the National Stock Exchange of India Limited regarding this development. Manish Narang, President - Legal, Company Secretary & Compliance Officer, signed the disclosure.
Historical Stock Returns for Alkem Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.47% | -3.67% | -2.03% | -7.20% | +7.87% | +65.93% |
What strategic priorities is Mrs. Singh expected to drive during her next five-year term?
How will the market react to the re-appointment announcement at the upcoming Annual General Meeting?
What are the potential implications of this leadership continuity on Alkem Laboratories' long-term growth plans?
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
